Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmune disorders in diabetes.

C Boitard, M Debray-Sachs, J F Bach

    Advances in Nephrology From the Necker Hospital
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    The immune system plays a key role in type 1 diabetes (IDDM) development, evidenced by autoantibodies and genetic links. Animal models confirm immune involvement in islet cell destruction, paving the way for targeted therapies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    COVID-19 epidemic phases: Criteria, challenges and issues for the future.

    Bulletin de l'Academie nationale de medecine·2020
    Same author

    [Covid-19 epidemic phases: Criteria, challenges and issues for the future].

    Bulletin de l'Academie nationale de medecine·2020
    Same author

    Value of magnetic resonance imaging for evaluating muscle inflammation: insights from a new mouse model of myositis.

    Neuropathology and applied neurobiology·2017
    Same author

    Impact of Early Consumption of High-Fat Diet on the Mesolimbic Dopaminergic System.

    eNeuro·2017
    Same author

    The Islet and Metabolism Keep Time.

    Diabetes, obesity & metabolism·2015
    Same author

    Circadian rhythm-related genes: implication in autoimmunity and type 1 diabetes.

    Diabetes, obesity & metabolism·2015

    Area of Science:

    • Immunology
    • Endocrinology
    • Genetics

    Background:

    • Type 1 diabetes (IDDM) development is linked to immune system markers.
    • Clinical and morphological evidence suggests autoimmune involvement in islet cell destruction.
    • Genetic associations, like with HLA-DR3 and DR4, indicate a predisposition to autoimmune phenomena.

    Purpose of the Study:

    • To investigate the role of the immune system in the pathogenesis of type 1 diabetes (IDDM).
    • To explore whether autoimmune responses are primary or secondary to initial islet damage.
    • To understand the molecular mechanisms underlying IDDM susceptibility and potential therapeutic targets.

    Main Methods:

    • Analysis of biologic markers, including anti-islet cell antibodies and T lymphocytes.

    Related Experiment Videos

  • Examination of genetic associations with HLA-DR alleles.
  • Utilizing animal models (BB rat, low-dose streptozotocin mouse) to study IDDM pathogenesis.
  • Employing hybridoma technology to identify target antigens.
  • Biochemical and functional studies of major histocompatibility complex (MHC) genes.

    • Main Results:

    • Animal models demonstrate that immune system interference can prevent IDDM.
    • The BB rat model shows spontaneous autoimmune IDDM without initial trigger.
    • The streptozotocin model reveals autoimmune IDDM secondary to toxin-induced islet damage.
    • Research is actively identifying target antigens and the role of MHC class II genes.

    Conclusions:

    • The immune system, particularly T lymphocytes and autoantibodies, is strongly implicated in the selective destruction of insulin-secreting cells in IDDM.
    • Animal models provide crucial insights into the autoimmune mechanisms driving IDDM.
    • Understanding target antigens and MHC gene roles is essential for developing antigen-specific immunotherapy for IDDM.